T-cell-based therapies for malignancy and infection in childhood

Nabil Ahmed, Helen E. Heslop, Crystal L. Mackall

Research output: Contribution to journalReview articlepeer-review

Abstract

One major advance in T-cell-based immunotherapy in the last 20 years has been the molecular definition of numerous viral and tumor antigens. Adoptive T-cell transfer has shown definite clinical benefit in the prophylaxis and treatment of viral infections that develop in pediatric patients after allogeneic transplant and in posttransplant lymphoproliferative disease associated with the Epstein-Barr virus. Developing adoptive T-cell therapies for other malignancies presents additional challenges. This article describes the recent advances in T-cell-based therapies for malignancy and infection in childhood and strategies to enhance the effector functions of T cells and optimize the cellular product, including gene modification and modulation of the host environment.

Original languageEnglish (US)
Pages (from-to)83-96
Number of pages14
JournalPediatric clinics of North America
Volume57
Issue number1
DOIs
StatePublished - Feb 1 2010

Keywords

  • Adoptive immunotherapy
  • Chimeric antigen receptor
  • Hematopoietic stem cell transplantation
  • Immune reconstitution
  • Lymphopenia
  • Pediatrics
  • Tumor antigens
  • Tumor vaccines

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'T-cell-based therapies for malignancy and infection in childhood'. Together they form a unique fingerprint.

Cite this